Cargando…

Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action

High-density lipoprotein cholesterol (HDL-C) has been identified as a powerful independent negative predictor of cardiovascular disease. The beneficial effect of HDL is largely attributable to its key role in reverse cholesterol transport, whereby excess cholesterol in the peripheral tissues is tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Manabu, Nakajima, Hideto, Toh, Ryuji, Hirata, Ken-ichi, Ishida, Tatsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193192/ https://www.ncbi.nlm.nih.gov/pubmed/30146614 http://dx.doi.org/10.5551/jat.RV17025

Ejemplares similares

High‐density lipoprotein protects cardiomyocytes from oxidative stress via the PI3K/mTOR signaling pathway
por: Nagao, Manabu, et al.
Publicado: (2017)

Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B(4) pathway by high-density lipoprotein in macrophages
por: Tsuda, Shigeyasu, et al.
Publicado: (2017)

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk
por: Murakami, Katsuhiro, et al.
Publicado: (2023)

2-Aminobutyric acid modulates glutathione homeostasis in the myocardium
por: Irino, Yasuhiro, et al.
Publicado: (2016)

Effects of Elaidic Acid on HDL Cholesterol Uptake Capacity
por: Iino, Takuya, et al.
Publicado: (2021)

AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice
por: Ma, Ang, et al.
Publicado: (2017)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?
por: Toh, Ryuji
Publicado: (2023)

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
por: Chan, Sammy Y, et al.
Publicado: (2008)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation
por: Satomi-Kobayashi, Seimi, et al.
Publicado: (2018)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Small Dense Low‐Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses
por: Stadler, Julia T., et al.
Publicado: (2022)

Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy
por: Mori, Kenta, et al.
Publicado: (2017)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
por: Syed, Shahan, et al.
Publicado: (2021)

Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins
por: Płaczkowska, Sylwia, et al.
Publicado: (2022)

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
por: Kim, Jae-Yong, et al.
Publicado: (2016)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

The Role of the Low-Density Lipoprotein/High-Density Lipoprotein Cholesterol Ratio as an Atherogenic Risk Factor in Young Adults with Ischemic Stroke: A Case—Control Study
por: Ciplak, Sibel, et al.
Publicado: (2023)

Anti-atherogenic Action of “Cardipro” - A Herbal Proprietary Formulation
por: Chatterjee, S., et al.
Publicado: (2001)

Association between Serum Elaidic Acid Concentration and Insulin Resistance in Two Japanese Cohorts with Different Lifestyles
por: Itcho, Kiyotaka, et al.
Publicado: (2017)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Tannerella forsythia is associated with increased levels of atherogenic low density lipoprotein and total cholesterol in chronic periodontitis
por: Ardila, Carlos M., et al.
Publicado: (2015)

The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
por: Komiyama, Maki, et al.
Publicado: (2014)

Effects of patient‐tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low‐density lipoprotein cholesterol in patients with type 2 diabetes
por: Son, Jang Won, et al.
Publicado: (2013)

Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
por: Hemmati, Mina, et al.
Publicado: (2015)

A Novel Indicator for HDL Functionality
por: Irino, Yasuhiro, et al.
Publicado: (2019)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012)

Tim-3 inhibits low-density lipoprotein-induced atherogenic responses in human umbilical vein endothelial cells
por: Qiu, Ming-Ke, et al.
Publicado: (2017)

Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
por: O’Morain, Victoria L., et al.
Publicado: (2023)

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
por: Cartolano, Flávia De C., et al.
Publicado: (2017)

In Vivo Imaging of Venous Thrombus and Pulmonary Embolism Using Novel Murine Venous Thromboembolism Model
por: Okano, Mitsumasa, et al.
Publicado: (2020)

Anti-Atherogenic Properties of Allium ursinum Liophylisate: Impact on Lipoprotein Homeostasis and Cardiac Biomarkers in Hypercholesterolemic Rabbits
por: Bombicz, Mariann, et al.
Publicado: (2016)

Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
por: Schekatolina, Svetlana, et al.
Publicado: (2022)

Insights into the Molecular Mechanisms of the Anti-Atherogenic Actions of Flavonoids in Normal and Obese Mice
por: Shabrova, Elena V., et al.
Publicado: (2011)

Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
por: Cartolano, Flavia De Conti, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ipleoruieao5dc417k7a7ao2gj